Top Markets
Coin of the day
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Classement en actions #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Prix de l'action
$0.01317984
Dernière synchronisation: 2026-08-17
Capitalisation boursière
$10.52M
Changement (1 jour)
-1.26%
Changement (1 an)
-53.51%
Pays
SE
Échange Spago Nanomedical AB (publ) (SPAGO)

Catégorie

Historique du rendement du dividende pour Spago Nanomedical AB (publ) (SPAGO)
Le rendement du dividende (TTM) de Spago Nanomedical AB (publ) (symbole boursier : SPAGO) au 2026 est : 0
Rendement moyen du dividende sur les 5 dernières années : 0.00%
Historique du rendement du dividende de Spago Nanomedical AB (publ) (SPAGO) de 2026 à 2026
Rendement du dividende à la fin de chaque année (TTM)
Année Rendement du dividende Changez
Pas assez de données pour les dates fournies.
Rendements du dividende (TTM) pour des entreprises similaires ou concurrentes